Medicare Will Now Cover Weight Loss Drugs for $50 — But There's a Catch

Medicare Will Now Cover Weight Loss Drugs for $50 — But There's a Catch Medicare is now covering GLP-1 weight loss drugs — but only if you qualify, and only for a limited time. Starting July 1, 2026, eligible Medicare beneficiaries can access GLP-1 medications like Wegovy and Zepbound for approximately $50 per month — down from nearly $1,000 per month. This is the Medicare GLP-1 Bridge Program, a temporary demonstration program running through December 31, 2027. In this video, I break down exactly what it covers, who qualifies, and what the fine print means for your Medicare coverage. Important Links: https://www.cms.gov/medicare/coverage... https://barleymedical.com/denials/glp... In this video: What the Medicare GLP-1 Bridge Program actually is (and what it isn't) Which GLP-1 drugs are included — Wegovy, Zepbound, Ozempic, Mounjaro, Tirzepatide, Semaglutide Eligibility requirements: BMI thresholds, qualifying conditions, and prior authorization Why the $50 copay does NOT count toward your Part D out-of-pocket limit How this affects your Medicare Part D and Medicare Advantage coverage Whether this could raise your future Medicare premiums What the BALANCE model means for 2027 plan selection The side effects and medical risks you need to discuss with your doctor Who qualifies for the Medicare GLP-1 Bridge Program? ✅ Enrolled in Medicare Part D (standalone or Medicare Advantage) ✅ BMI of 35 or higher ✅ OR BMI of 27+ with qualifying health conditions (e.g., high blood pressure) ✅ Prior authorization and physician documentation required ⚠️ This is a temporary demonstration program — not a permanent law change. Permanent Medicare coverage of obesity medications would require an act of Congress. Do not assume your current Part D plan handles this automatically. Steps to take now: Talk to your doctor about your BMI and medical history Review your current Part D or Medicare Advantage drug formulary Watch for updated CMS guidance as operational details are still being released Pay close attention to your Annual Enrollment Period decisions for 2027 📞 Questions about your Medicare coverage? Visit us at MedigapSeminars.org or call us directly — no sales pressure, just straight answers. *Video Title:* Medicare Will Now Cover Weight Loss Drugs for $50 — But There's a Catch 00:00 — Breaking Medicare News: $50 GLP-1 Weight Loss Drugs 00:00:49 — What Is the Medicare GLP-1 Bridge Program? 00:01:28 — The Hidden Catch Most Headlines Ignore 00:02:10 — Why Medicare Usually Does NOT Cover Weight Loss Drugs 00:02:57 — How CMS Is Working Around the Medicare Law 00:03:26 — Temporary Program vs Permanent Medicare Coverage 00:04:02 — Who Actually Qualifies for $50 Wegovy or Zepbound? 00:04:40 — The Biggest Misunderstanding About Eligibility 00:05:18 — Wegovy vs Ozempic | Zepbound vs Mounjaro Explained 00:06:28 — Which GLP-1 Drugs Medicare May Cover 00:07:03 — Standard Part D Coverage vs Bridge Program Coverage 00:07:11 — Does the $50 Copay Really Apply to Everyone? 00:07:46 — Why the GLP-1 Program Works Outside Medicare Part D 00:07:59 — TROOP, Out-of-Pocket Costs & Low Income Subsidy Explained 00:08:18 — Why This Does NOT Count Toward Your Part D Spending Limit 00:09:00 — Will GLP-1 Coverage Increase Medicare Premiums? 00:10:00 — What Happens If Medicare Permanently Covers Weight Loss Drugs? 00:11:02 — The Long-Term Cost Risk to Medicare and Taxpayers 00:12:59 — Medicare GLP-1 Program Start Date: July 1, 2026 00:13:11 — What Medicare Beneficiaries Should Do Right Now 00:13:31 — Why Your Current Part D Plan May Not Handle This Automatically 00:14:00 — How 2027 Medicare Part D Changes Could Affect GLP-1 Coverage 00:14:24 — The Bigger Medicare Story Nobody Is Talking About 00:15:10 — Why CMS Calls This a “Temporary Test Program” 00:15:29 — Will Congress Permanently Approve Medicare Weight Loss Coverage? 00:15:59 — Final Takeaways: Who Gets Covered and What to Watch Next Matthew Claassen — MedigapSeminars.org Medicare education without the sales pitch. #Medicare #GLP1 #WeightLossDrugs #Wegovy #Zepbound #MedicarePartD #MedicareAdvantage #Tirzepatide #MedicareExplained #ozempic Call Us today: 800-847-9680 https://medigapseminars.org/contact-us/ https://medigapseminars.org/request-a... Visit our Podcast: https://medicarepodcasts.com/